News

Blood tests can be an important part of a pancreatic cancer diagnosis. With this type of cancer, a timely diagnosis is vital, however, pancreatic cancer is often difficult to detect early.
Just one drop of blood could reveal if you have pancreatic cancer. A new test called PAC-MANN can pick up signs of the disease in people’s blood, even at an early stage, researchers report ...
Seven warning signs of pancreatic cancer you shouldn't ignore as these subtle symptoms often get dismissed but could save ...
Metastatic pancreatic ductal adenocarcinoma, the most common and deadly form of pancreatic cancer, is seen here. Getty Images/iStockphoto. PAC-MANN was created using blood samples from 350 ...
Pancreatic cancer has a low survival rate and is usually found too late — this new test may help change that Getty Researchers have developed an inexpensive blood test that they say can detect ...
The test claims to analyse epigenomic and genomic data from circulating, cell-free DNA obtained from a simple blood draw.
Pancreatic cancer is a relatively rare form of cancer when it comes to cases diagnosed per year. However, it remains a deadly type of cancer that accounts for a high percentage of annual deaths when ...
Searching blood samples of pancreatic cancer patients and controls for a distinctive molecule given off by the malignancy, scientists were even able to distinguish subjects with benign pancreatic ...
A new test designed to detect markers in the blood is accurately predicting which patients might be developing pancreatic cancer, meaning they can have potentially life-saving treatment.
This fast-moving cancer starts in the pancreas—a gland behind the stomach that helps with digestion and blood sugar control. Early detection is vital. Many signs of pancreatic cancer overlap ...
Pancreatic cancer is nearly impossible to treat, but now we may know why. New research shows that the tumors destroy nearby blood vessels, making it harder for drugs to reach them.
A new study has found a link between high blood insulin levels, frequently seen in people with obesity and type 2 diabetes, and pancreatic cancer. The researchers say their findings may lead to ...